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Background. Obstructive sleep apnea (OSA) syndrome is one of the most common respiratory disorders in humans. There is
emerging evidence linkingOSA to vascular disease, particularly hypertension.The underlying pathophysiological mechanisms that
linkOSA to cardiovascular diseases such as hypertension, congestive heart failure, and atrial fibrillation are not entirely understood.
The aim of this study was to investigate the association of obstructive sleep apnea hypopnea syndrome (OSAHS) with coronary
atherosclerotic disease (CAD).Methods. A questionnaire survey based on Berlin questionnaire and Epworth Sleepiness Scale (ESS)
was conducted among 406 patients to assess demographic data and the symptoms, such as excessive daytime sleepiness and snoring.
Epworth Sleepiness Scale and Berlin questionnaire were completed by all of the patients. Venous blood samples were obtained for
biochemical tests. Characteristics of coronary arteries were collected from angiographies’ reports. All patients were divided into two
groups based on results from Berlin questionnaire: low risk patients for OSA and high risk patients for OSA. Data were analyzed
by SPSS software version 13. Results. Mean age of patients was 61.8 ± 10.5. 212 (52.2%) patients were categorized as high risk group
for apnea. Also, excessive daytime sleepiness was reported in 186 patients (45.8%). The severity of coronary artery involvement,
daytime sleepiness, and electrocardiogram abnormalities was significantly higher in high risk patients for OSA compared with low
risk patients. High risk patients had higher level of FBS and LDL and lower level of HDL cholesterol (𝑃 < 0.05). Conclusion. Our
study found a strong correlation between the number of stenotic vessels andOSA. Based on our findings, OSA can be a predisposing
factor for cardiac diseases.
1. Introduction
Obstructive sleep apnea syndrome (OSAS) is a common
disorder. It is estimated that 4% of males and 2% of females
suffer from this disorder [1]. The clinical findings associated
with sleep apnea are habitual snoring and disturbance in
sleep quality and daily cognitive dysfunction.The respiratory
disorders have not only effect on sleep quality but also have
destructive effects on the quality of waking hours. Excessive
sleepiness during the day time is one of themain signs of sleep
apnea syndrome [2–4].
Different studies showed that obstructive sleep apnea
(OSA) may be a risk factor for incidence of some medical
conditions such as diabetes type 2 and headache. Car-
diovascular diseases are a group of disorders which have
causal relationship with sleep apnea. According to surveys,
the incidence of OSA in patients with cardiovascular diseases
is 30 to 50 percent [5, 6]. The correlation between some
cardiovascular diseaseswith sleep apnea is investigated.These
are hypertension, myocardial infarction, arrhythmia, cardi-
omyopathies, heart failure, and cardiac attack [7–9].
The standard method for diagnosis of OSA is over-
night polysomnography (PSG). PSG included electroen-
cephalogram, electromyogram, electrocardiogram (ECG),
oxymetery, oronasal air flow, and respiratory efforts. These
parameters can determine existence and intensity of sleep
apnea. Using standard PSG for screening purpose is impos-
sible, because of high cost and time consumption of this
procedure. There are also some questionnaires that assess
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the probability of sleep apnea occurrence. Among them,
Berlin questionnaire and Epworth Sleepiness Scale (ESS) are
the most commonmethods used for sleep apnea screening in
several studies [10].
ESS is a method for evaluation of excessive drowsiness
during the day. However, this is a subjective method, non-
expensive, easy to do, and available [11].
A survey on patients with OSA in 20 teaching hospitals
showed that results of ESS compared with PSG findings for
assessing apnea. Sensitivity and specificity of Berlin question-
naire for assessingOSA are 85% and 77%, respectively [12, 13].
According to findings of above-mentioned studies, this
study is designed to assess the prevalence of OSA and its rela-
tion to angiography’s results in patients with cardiovascular
diseases.
2. Material and Methods
Subjects were patients (male or female) aged less than 70
years old who were scheduled for coronary angiography. In
this prospective study, all patients were recruited at the Heart
Clinic of Boali-SinaUniversityHospital fromMay toOctober
2009. Indications for cardiac catheterization were history of
chest pain or pathologic findings in exercise ECG. A total of
845 patients were recruited for the study, and 406 of themhad
criteria for doing angiography test.
Both right and left coronary angiograms were performed
in all patients. Coronary artery stenosis was considered
significant if there was ≥70% diameter stenosis.
Patients with history of cerebrovascular attack (CVA),
COPD, and heart failure and who took sedative drugs were
excluded from study. Patients with oxygen dependency and
coronary disorders with ejection fraction less than 40% were
excluded too.The study protocolwas explained for all patients
and written informed consent was obtained from all subjects.
Height, weight, and waist and neck circumferences were
measured for all subjects. Body mass index (BMI) was
calculated by dividing weight (Kilogram) on squared height
(Meter). Blood pressure also was measured with mercury
barometer.
Demographic characteristics were collected using a ques-
tionnaire including age and sex. ESS and Berlin question-
naires were filled out for all subjects.The ESS is an eight-item
questionnaire that is a simple and inexpensive instrument
to measure subjective daytime sleepiness. The cutoff point
for excessive daytime sleepiness is considered to be equal or
greater than 10 [12]. Berlin questionnaire has three categories.
The first category has five questions about snoring. Second
category with four questions is about daytime somnolence.
The last category with 1 question asks about high blood
pressure. High risk for OSA is considered if two or more
categories are positive [13].
Venous blood samples obtained for biochemical tests
including LDL cholesterol, HDL cholesterol, and fasting
blood sugar (FBS). ECG characteristics (like heart rhythm,
rate, ischemic changes, and ST elevation and necrosis signs)
were noted.
All data were processed by SPSS software version 13. Data
are shown as the mean ± standard deviation or number
Table 1: Demographic characteristics and clinical findings in






Age 61.4 ± 10.6 63.8 ± 9.3 0.09
Gender
Male 61 (15%) 174 (42.8%) 0.041
Female 133 (32.7%) 38 (9.3%)
BMI 25.7 ± 3.4 27.6 ± 3.7 0.039
Smoking
Yes 64 (15.7%) 78 (19.2%) 0.076








circumference 91.8 ± 8.3 (83–95) 93.6 ± 8.9 (84–98) 0.034
∗Data are number (percentage) and mean ± standard deviation (minimum–
maximum).





patients𝑁 = 212 𝑃 value
Triglyceride
(mmol/L) 137.1 ± 9.2 183.5 ± 14.9 0.004
HDL (mmol/L) 31.2 ± 5.2 27.8 ± 6.1 0.018
Fasting blood sugar
(mg/dL) 107.5 ± 9.3 126.8 ± 6.7 0.001
Blood pressure (sys) 118.8 ± 20 132.2 ± 15.5 0.024
ESS 10.3 ± 4.7 13.8 ± 4.8 0.007
Number of vessels
One vessel 118 (60.2%) 78 (39.8%)
0.005Two vessels 61 (35.9%) 109 (64.1%)
Three vessels 15 (37.5%) 25 (62.5%)
EKG
Ischemic 69 (17%) 99 (24.4%)
Nonischemic 125 (30.8%) 113 (27.8%) 0.004
Q-wave 24 (5.9%) 64 (15.8%)
Non-Q-wave 170 (41.9%) 148 (36.4%) 0.002
ST elevation 25 (5.7%) 97 (23.9%)
Non-ST elevation 169 (42.1%) 115 (28.3%) 0.004
ST depression 79 (19.4%) 92 (22.7%)
Non-ST depression 119 (29.3%) 116 (28.6%) 0.083
∗Data are presented as number (percentage) andmean± standard deviation.
(percentage). Differences between groups were analyzed by
Student 𝑡-test, Chi-squared test, and one-way analysis of vari-
ance. Logistic regression was used to calculate the odds ratio
(OR) and confidence interval of variables, while adjusting for
possible confounders. Predictive value (𝑃 value) less than 0.05
was considered significant.
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Table 3: Comparing Berlin questioner, ESS, and other CV risk factors with coronary artery disease severity (1-, 2-, and 3-vessel disease of
Gensini score).







ESS 9.2 ± 2.7 11.7 ± 3.1 12.2 ± 1.6 <0.001
Patients with OSA 95 (23.4%) 53 (13%) 64 (15.6%) 0.002
Triglyceride 145.7 ± 12.3 137 ± 9.3 178 ± 7.9 0.03
HDL 37.2 ± 7.2 26.9 ± 4.9 29.1 ± 6.1 0.009
Fasting blood sugar 109.8 ± 8.9 129.8 ± 9.4 136.4 ± 14.1 0.03
Blood pressure (sys) 115.8 ± 6.9 139.5 ± 9.3 145.8 ± 14.1 0.007
∗Data are presented as mean ± SD and number (percentage).
Table 4: Univariate and multivariate logistic regression results on associated factors of the presence of OSA.
High risk of OSA
𝑁 (%)
Univariate relative risk
OR (95% CI) 𝑃 value
Multivariate relative risk
OR (95% CI) 𝑃 value
Age — — 0.12 — 0.08
Gender
Male 174 (42.8%) 1.3 (1.1–1.5) 0.003 1.25 (1.2–1.4) 0.001
Female 38 (9.3%)
BMI — 1.1 (1.08–1.12) 0.01 1.1 (1.9–1.11) 0.01
Smoking
Yes 78 (19.2%) — 0.21 — 0.076
No 134 (33%)
Neck circumference 37.6 ± 1.4 2.1 (1.3–2.4) 0.02 2.1 (1.5–2.3) 0.004
Waist circumference 93.6 ± 8.9 1.4 (1.1–1.8) 0.01 1.4 (1.2–1.8) 0.002
TG (mmol/L) ≥150mg/dL 316 (77.8%) 3.1 (2.4–4.2) 0.004 3.1 (2.5–4.1) 0.001
HDL (mmol/L) ≤40mg/dL 288 (70.9%) 1.9 (1.4–2.8) 0.008 1.8 (1.4–2.7) 0.002
FBS >110 76 (18.7%) 2.7 (1.6–3.5) 0.02 2.8 (1.9–3.2) 0.006
Blood pressure (sys) 132.2 ± 15.5 2.1 (1.3–2.6) 0.005 2.3 (1.4–2.5) 0.003
3. Results
Subjects mean age was 61.83±10.5 years old (ranged from 40
to 70 years old). Mean value of BMI and neck circumference
were 26.7 ± 3.6Kg/m2 and 37.4 ± 1.4 cm, respectively.
Among subjects, 212 (52.2%)were categorized as high risk
group for apnea and 194 (47.8%) as low risk group. Findings of
ESS questionnaire were as follows: 220 (54.2%) were without
sleepiness (ESS < 10) and excessive daytime sleepiness was
reported in 186 (45.8%).
Studied parameters are shown in Tables 1 and 2. Table 3
compares Berlin questionnaire, ESS, and other CV risk
factors in patients with different severity of coronary artery
disease (1-, 2-, and 3-vessel disease of Gensini score).
Table 4 shows the results of the logistic regression anal-
ysis on the associated factors of the presence of high risk
of obstructive sleep apnea. The variables included in the
univariate and multivariate regression model were age, sex,
BMI, smoking, neck circumference, waist circumference,
triglyceride, HDL cholesterol, FBS, daytime sleepiness, and
number of vessels with stenosis in angiography. As the table
shows, gender and BMI were not statistically associated with
the presence of OSA. The variables with the highest ORs
related to the presence of OSA were sex, FBS, daytime sleepi-
ness, and number of vessels with stenosis in angiography.
4. Discussion
In the present study, high prevalence of OSA was reported
in patients scheduled for angiography. Some studies showed
that sleep breathing disorders independent of other risk
factors can be an important risk factor for cardiovascular
diseases. On the other hand, sleep breathing disorders can
increase incidence of cardiovascular diseases more than two-
to threefold comparedwith populationwithout it [1–4].Thus,
OSA coexists in 30 to 50 percent of patients with coronary
heart diseases [5].
Our findings also demonstrated that the intensity of coro-
nary artery disease is higher in patients with OSA compared
with the others. In the present study, patients with 2 to 3
vessels stenosis were classified in high risk group for apnea
(according to Berlin questionnaire), while patients with
4 Cardiovascular Psychiatry and Neurology
single vessel disease had low risk for OSA. These findings
are consistent with data from other studies. The study con-
ducted by American Sleep Research Center showed that risk
of cardiovascular events in patients with Apnea-Hypopnea
Index (AHI) more than 5/hour is higher than those without
apnea [14]. In the other studies, authors revealed that subjects
with AHI more than 20/hour have higher risk of myocardial
infarction, angina, and coronary events [15, 16].
The mechanism of this correlation is not well known, but
the evidences imply that breathing disorders during sleep can
result in high systolic blood pressure. Other studies showed
that OSA can also result in increased fibrinogen and C-
reactive protein levels.These substances can be the initial step
of thrombosis process in coronary arteries [17].
In present study, OSA signs were common in patients
and were correlated with coronary stenosis. We evaluated
daytime sleepiness by using of ESS questionnaire. There was
a significant correlation between excessive sleepiness during
day (as a sign of OSA) and intensity of OSA. Parish and
Somers studied 175 patients with coronary artery disease
and demonstrated that 56% of them suffered from snoring
[18]. Other findings from present study showed that 39% of
patients with single coronary artery stenosis had high risk
of having OSA screened by Berlin questionnaire, while 60
and 62 percent of patients with 2 or 3 vessels stenosis were
stratified in high risk group for OSA.
The relation between OSA and coronary artery disease
was studied frequently. Young et al. reported that the percent-
age of two or three vessels disease was only 12% in patients
without OSA, but 80% of patients with OSA have stenosis
in at least two coronary vessels [1]. These evidences imply
the significant correlation between OSA and coronary artery
disease.
We also studied the relation between ECG characteristics
and parameters filled out in Berlin questionnaire. 60% of
patients with ischemic evidence in ECG and 81% of patients
who had pathologic Q in their ECG were also categorized in
the group with high risk for OSA. Mooe et al. showed that
30% of patients who had ST-depression in their ECG were in
high risk group for OSA [4].
We detected the lower level of HDL cholesterol and
higher level of triglyceride in patients with high risk of OSA
compared with patients with low risk of OSA. Pang and
Terris revealed the significant correlation between hyper-
cholesterolemia (specially the LDL cholesterol level) with
heart diseases [10]. The findings of another study in German
population showed that continuous positive airway pressure
(CPAP) can increase HDL cholesterol level and decline the
LDL cholesterol level in patients with OSA [19].
There were some limitations in our study. First of all we
could not use polysomnography for diagnosis of apnea. We
did not use PSG for our participants, owing to high cost and
inconvenience for hospitalized patients. Secondly, we could
not control the effect of all CAD risk factors.Thatwas because
of multiplicity of risk factors associated with coronary artery
disease.
Based on our findings, OSA can be a predisposing factor
for cardiac diseases. It seems that screening of OSA is
beneficial in patients with cardiac diseases or even patients
with hypertriglyceridemia or patients with low level of HDL
cholesterol which does not respond to therapy. It can lead to
early treatment and prevent the highmorbidity andmortality
rate of heart diseases. It can be also cost-beneficial, because it
decreases the rate of coronary bypass and hospitalization.
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